Furthermore, NLGN3 has been shown to phosphorylate key receptors on tumor cells, including VEGF, epidermal growth factor receptor (EGFR), fibroblast growth factor receptor (FGFR), and integrins, thus exerting their biological effects [27, 45, 143]. Here, EGFR is linked to neoplasm.